Allison Freedman is opening up about her fight with multiple myeloma during Blood Cancer Awareness Month. She went from being in the emergency room to conquering Mount Kilimanjaro.

The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...

Everything we covered on WTR over the past seven days, and all you need to know from the world of trademarks to set yourself up for the start of another busy week.

Niger has become the latest West African country to roll out malaria vaccines to try to stifle the potentially deadly disease ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

Shields has been vocal about women's wellness and now backs an initiative for women to be aware of an infection that's ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Climate Asset Management has raised more than $1 billion to invest in natural capital projects such as regenerative agriculture, its chief executive told Reuters.

Household confidence has sunk as concerns grow that Rachel Reeves and Sir Keir Starmer are talking Britain into a downturn.